Catheter ablation for atrial fibrillation in congestive heart failure
- PMID: 15575053
- DOI: 10.1056/NEJMoa041018
Catheter ablation for atrial fibrillation in congestive heart failure
Abstract
Background: Congestive heart failure and atrial fibrillation often coexist, and each adversely affects the other with respect to management and prognosis. We prospectively evaluated the effect of catheter ablation for atrial fibrillation on left ventricular function in patients with heart failure.
Methods: We studied 58 consecutive patients with congestive heart failure and a left ventricular ejection fraction of less than 45 percent who were undergoing catheter ablation for atrial fibrillation. We selected as controls 58 patients without congestive heart failure who were undergoing ablation for atrial fibrillation, matched according to age, sex, and classification of atrial fibrillation. We evaluated the patients' left ventricular function and dimensions, symptom score, exercise capacity, and quality of life at baseline and at months 1, 3, 6, and 12.
Results: After a mean (+/-SD) of 12+/-7 months, 78 percent of the patients with congestive heart failure and 84 percent of the controls remained in sinus rhythm (P=0.34) (69 percent and 71 percent, respectively, were in sinus rhythm without the administration of antiarrhythmic drugs). The patients with congestive heart failure had significant improvement in left ventricular function (increases in the ejection fraction and fractional shortening of 21+/-13 percent and 11+/-7 percent, respectively; P<0.001 for both comparisons), left ventricular dimensions (decreases in the diastolic and systolic diameters of 6+/-6 mm and 8+/-7 mm, respectively; P=0.03 and P<0.001, respectively), exercise capacity, symptoms, and quality of life. The ejection fraction improved significantly not only in patients without concurrent structural heart disease (24+/-10 percent, P<0.001) and those with inadequate rate control before ablation (23+/-10 percent, P<0.001), but also in those with coexisting heart disease (16+/-14 percent, P<0.001) and adequate rate control before ablation (17+/-15 percent, P<0.001).
Conclusions: Restoration and maintenance of sinus rhythm by catheter ablation without the use of drugs in patients with congestive heart failure and atrial fibrillation significantly improve cardiac function, symptoms, exercise capacity, and quality of life.
Copyright 2004 Massachusetts Medical Society.
Comment in
-
Atrial fibrillation and heart failure--five more years.N Engl J Med. 2004 Dec 2;351(23):2437-40. doi: 10.1056/NEJMe048248. N Engl J Med. 2004. PMID: 15575062 No abstract available.
-
Ablation for atrial fibrillation in congestive heart failure.N Engl J Med. 2005 Mar 17;352(11):1148-9; author reply 1148-9. doi: 10.1056/NEJM200503173521118. N Engl J Med. 2005. PMID: 15784670 No abstract available.
-
Ablation for atrial fibrillation in congestive heart failure.N Engl J Med. 2005 Mar 17;352(11):1148-9; author reply 1148-9. N Engl J Med. 2005. PMID: 15789455 No abstract available.
-
Catheter ablation for atrial fibrillation in heart failure patients.Curr Cardiol Rep. 2005 May;7(3):194-5; discussion 195. Curr Cardiol Rep. 2005. PMID: 15865860 No abstract available.
Similar articles
-
The Ablate and Pace Trial: a prospective study of catheter ablation of the AV conduction system and permanent pacemaker implantation for treatment of atrial fibrillation. APT Investigators.J Interv Card Electrophysiol. 1998 Jun;2(2):121-35. doi: 10.1023/a:1009795330454. J Interv Card Electrophysiol. 1998. PMID: 9870004
-
Efficacy, safety, and outcomes of catheter ablation of atrial fibrillation in patients with heart failure with preserved ejection fraction.J Am Coll Cardiol. 2013 Nov 12;62(20):1857-65. doi: 10.1016/j.jacc.2013.07.020. Epub 2013 Jul 31. J Am Coll Cardiol. 2013. PMID: 23916940
-
Catheter ablation of atrial fibrillation in heart failure.Heart Fail Clin. 2013 Oct;9(4):515-32, ix. doi: 10.1016/j.hfc.2013.07.006. Epub 2013 Aug 12. Heart Fail Clin. 2013. PMID: 24054483 Review.
-
Sinus rhythm restores ventricular function in patients with cardiomyopathy and no late gadolinium enhancement on cardiac magnetic resonance imaging who undergo catheter ablation for atrial fibrillation.Heart Rhythm. 2013 Sep;10(9):1334-9. doi: 10.1016/j.hrthm.2013.06.019. Epub 2013 Jun 27. Heart Rhythm. 2013. PMID: 23811081
-
Catheter ablation of atrial fibrillation in heart failure with reduced ejection fraction.J Cardiovasc Electrophysiol. 2018 Jul;29(7):1049-1058. doi: 10.1111/jce.13497. Epub 2018 Apr 23. J Cardiovasc Electrophysiol. 2018. PMID: 29630760 Review.
Cited by
-
Cardiac remodelling in patients with atrial fibrillation and obstructive sleep apnoea.Open Heart. 2024 Oct 30;11(2):e002718. doi: 10.1136/openhrt-2024-002718. Open Heart. 2024. PMID: 39477342 Free PMC article. Clinical Trial.
-
Ablation therapy following unsuccessful electrical cardioversion in patients with persistent atrial fibrillation.Sci Rep. 2024 Oct 7;14(1):23289. doi: 10.1038/s41598-024-73989-2. Sci Rep. 2024. PMID: 39375426 Free PMC article.
-
Does Sinus Rhythm Restoration in Patients With Atrial Fibrillation Undergoing Pulmonary Vein Isolation Have Acute Hemodynamic Benefits?Cardiol Res. 2024 Aug;15(4):298-308. doi: 10.14740/cr1692. Epub 2024 Aug 20. Cardiol Res. 2024. PMID: 39205957 Free PMC article.
-
Contributions of France to the field of clinical cardiac electrophysiology and pacing.Heart Rhythm O2. 2024 Jul 19;5(7):490-514. doi: 10.1016/j.hroo.2024.02.005. eCollection 2024 Jul. Heart Rhythm O2. 2024. PMID: 39119028 Free PMC article. No abstract available.
-
Atrial fibrillation burden: a new outcome predictor and therapeutic target.Eur Heart J. 2024 Aug 16;45(31):2824-2838. doi: 10.1093/eurheartj/ehae373. Eur Heart J. 2024. PMID: 38953776 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical